Monday - March 17, 2025
HHS National Institute of Allergy & Infectious Diseases: As Prevention Strategy for Sexually Transmitted Infections Rolls Out, Experts Highlight Both Promise, Knowledge Gaps
January 07, 2025
WASHINGTON, Jan. 7 (TNSres) -- The U.S. Department of Health and Human Services National Institute of Allergy and Infectious Diseases issued the following news release:

* * *

Doxycycline has Population-Level Benefits, Warrants Vigilance for Antimicrobial Resistance

* * *

As health care services begin offering doxycycline to prevent bacterial sexually transmitted infections (STIs), real-world evidence demonstrates that the postexposure strategy, . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products